These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34751576)

  • 1. Streamlining Peptide Mapping LC-MS Approach for Studying Fusion Peptide-Conjugated Vaccine Immunogens.
    Ivleva VB; Gowetski DB; Lei QP
    J Am Soc Mass Spectrom; 2021 Dec; 32(12):2777-2790. PubMed ID: 34751576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen.
    Ou L; Kong WP; Chuang GY; Ghosh M; Gulla K; O'Dell S; Varriale J; Barefoot N; Changela A; Chao CW; Cheng C; Druz A; Kong R; McKee K; Rawi R; Sarfo EK; Schön A; Shaddeau A; Tsybovsky Y; Verardi R; Wang S; Wanninger TG; Xu K; Yang GJ; Zhang B; Zhang Y; Zhou T; ; Arnold FJ; Doria-Rose NA; Lei QP; Ryan ET; Vann WF; Mascola JR; Kwong PD
    Sci Rep; 2020 Feb; 10(1):3032. PubMed ID: 32080235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique algorithm for the determination of peptide-carrier protein conjugation ratio by amino acid analysis using intrinsic internal standard.
    Yang GJ; Yang Y; Shaddeau A; Cai CX; Li Y; Gulla K; Zhang Y; Ou L; Cooper JW; Lei QP
    Vaccine; 2020 Jun; 38(29):4507-4511. PubMed ID: 32448620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry.
    Hernandez-Alba O; Houel S; Hessmann S; Erb S; Rabuka D; Huguet R; Josephs J; Beck A; Drake PM; Cianférani S
    J Am Soc Mass Spectrom; 2019 Nov; 30(11):2419-2429. PubMed ID: 31429052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a recombinant influenza vaccine candidate using complementary LC-MS methods.
    Xie H; Doneanu C; Chen W; Rininger J; Mazzeo JR
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1568-79. PubMed ID: 21542793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Cysteine Modifications in Recombinant Protein Tetanus Toxoid Heavy Chain Fragment C.
    Cai CX; Schneck NA; Cozine T; Ivleva VB; Ragheb D; Gollapudi D; Patel A; Barefoot N; Gowetski DB; Lei QP
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1837-1840. PubMed ID: 34167299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-Specific Conjugation Quantitation of a Cysteine-Conjugated Antibody-Drug Conjugate Using Stable Isotope Labeling Peptide Mapping LC-MS/MS Analysis.
    Davis TK; Jennings ME
    Anal Chem; 2022 Feb; 94(6):2772-2778. PubMed ID: 35100801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Resolution Ion-Mobility-Enabled Peptide Mapping for High-Throughput Critical Quality Attribute Monitoring.
    Arndt JR; Wormwood Moser KL; Van Aken G; Doyle RM; Talamantes T; DeBord D; Maxon L; Stafford G; Fjeldsted J; Miller B; Sherman M
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2019-2032. PubMed ID: 33835810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.
    Xie H; Gilar M; Gebler JC
    Anal Chem; 2009 Jul; 81(14):5699-708. PubMed ID: 19518054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation Site Analysis by MS/MS Protein Sequencing.
    Han L; Zhao Y; Zhang Q
    Methods Mol Biol; 2020; 2078():221-233. PubMed ID: 31643060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Resolution Capillary Zone Electrophoresis with Mass Spectrometry Peptide Mapping of Therapeutic Proteins: Peptide Recovery and Post-translational Modification Analysis in Monoclonal Antibodies and Antibody-Drug Conjugates.
    Dada OO; Zhao Y; Jaya N; Salas-Solano O
    Anal Chem; 2017 Nov; 89(21):11236-11242. PubMed ID: 28984442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Analytical Characterization of Glycoconjugate Vaccines through Combined High-Resolution MS and NMR: Application to Neisseria meningitidis Serogroup B Oligosaccharide-Peptide Glycoconjugates.
    Yu H; An Y; Battistel MD; Cipollo JF; Freedberg DI
    Anal Chem; 2018 Apr; 90(8):5040-5047. PubMed ID: 29561588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Larson EJ; Zhu Y; Wu Z; Chen B; Zhang Z; Zhou S; Han L; Zhang Q; Ge Y
    Anal Chem; 2020 Nov; 92(22):15096-15103. PubMed ID: 33108180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1.
    Ou L; Gulla K; Biju A; Biner DW; Bylund T; Changela A; Chen SJ; Zheng CY; Cibelli N; Corrigan AR; Duan H; Gonelli CA; Kong WP; Cheng C; O'Dell S; Sarfo EK; Shaddeau A; Wang S; Vinitsky A; Yang Y; Zhang B; Zhang Y; Koup RA; Doria-Rose NA; Gall JG; Mascola JR; Kwong PD
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
    Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y
    MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring multiple quality attributes of a complex Fc-fusion protein during cell culture production processes by mD-LC-MS peptide mapping.
    Camperi J; Dahotre S; Guillarme D; Stella C
    Talanta; 2022 Aug; 246():123519. PubMed ID: 35525056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.